For instance, the E3 ubiquitin ligase FBXL6 promotes tumor metastasis through the KRAS/MEK/ERK/mTOR pathway, and this effect is significantly blocked by the mTOR inhibitor everolimus and the MEK inhibitor trametinib [128]. This evidence concerns the gene MAP2K7 and neoplasm.